.

.


The information on this site is from academic and research studies. Applicability to humans must be determined by a licensed medical professional.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included. There is an intentional delay in making those available.

  1. The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice.
    Biochemical pharmacology (Biochem Pharmacol ) Vol: 82 Issue 12 Pages: 1891-900
    Pub: 2011 Dec 15 Epub: 2011 Sep 16
    • Garrido-Mesa N
    • Utrilla P
    • Comalada M
    • Zorrilla P
    • Garrido-Mesa J
    • Zarzuelo A
    • Rodríguez-Cabezas ME
    • Gálvez J

  2. An in vitro study to assess the impact of tetracycline on the human intestinal microbiome.
    Anaerobe (Anaerobe ) Vol: 49 Issue Pages: 85-94
    Pub: 2017 Dec 30 Epub: 2017 Dec 30
    • Jung JY
    • Ahn Y
    • Khare S
    • Gokulan K
    • Piñeiro SA
    • Cerniglia CE

  3. Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients.
    Diagnostic microbiology and infectious disease (Diagn Microbiol Infect Dis ) Vol: 47 Issue 3 Pages: 527-37
    Pub: 2003 Nov Epub:
    • Casellas JM
    • Tomé G
    • Bantar C
    • Bertolini P
    • Blázquez N
    • Borda N
    • Couto E
    • Cudmani N
    • Guerrera J
    • Juárez MJ
    • López T
    • Littvik A
    • Méndez E
    • Notario R
    • Ponce G
    • Quinteros M
    • Salamone F
    • Sparo M
    • Sutich E
    • Vaylet S
    • Wolff L

  4. Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001.
    Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother ) Vol: 47 Issue 5 Pages: 1672-80
    Pub: 2003 May Epub:
    • Karlowsky JA
    • Jones ME
    • Thornsberry C
    • Friedland IR
    • Sahm DF

  5. Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora.
    Scandinavian journal of infectious diseases (Scand J Infect Dis ) Vol: 32 Issue 1 Pages: 81-5
    Pub: 2000 Epub:
    • Edlund C
    • Beyer G
    • Hiemer-Bau M
    • Ziege S
    • Lode H
    • Nord CE

  6. Sitafloxacin: in bacterial infections.
    Drugs (Drugs ) Vol: 71 Issue 6 Pages: 731-44
    Pub: 2011 Apr 16 Epub:
    • Keating GM

  7. Ceftriaxone promotes the emergence of AmpC-overproducing Enterobacteriaceae in gut microbiota from hospitalized patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (Eur J Clin Microbiol Infect Dis ) Vol: 37 Issue 3 Pages: 417-421
    Pub: 2018 Mar Epub: 2018 Jan 10
    • de Lastours V
    • Goulenok T
    • Guérin F
    • Jacquier H
    • Eyma C
    • Chau F
    • Cattoir V
    • Fantin B

  8. Infectious Disease and Antibmicrobial Agents
    antimicrobe: Infectious Disease and Antibmicrobial Agents (Antimicrobe ) Vol: Issue Pages:
    Pub: Epub:
    • E-Sun Technologies

  9. In vitro activities of 36 antimicrobial agents against clinically isolated Bacteroides fragilis.
    Journal of the Formosan Medical Association = Taiwan yi zhi (J Formos Med Assoc ) Vol: 90 Issue 8 Pages: 796-9
    Pub: 1991 Aug Epub:
    • Teng LJ
    • Ho SW
    • Chang SC
    • Luh KT
    • Hsieh WC

  10. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection.
    Infection and immunity (Infect Immun ) Vol: 76 Issue 10 Pages: 4726-36
    Pub: 2008 Oct Epub: 2008 Aug 4
    • Sekirov I
    • Tam NM
    • Jogova M
    • Robertson ML
    • Li Y
    • Lupp C
    • Finlay BB

Full list available by paid subscriptions

For More information see this summary.